TBPH Annual CAPEX
$2.49 M
+$1.92 M+334.97%
31 December 2023
Summary:
As of January 23, 2025, TBPH annual capital expenditures is $2.49 million, with the most recent change of +$1.92 million (+334.97%) on December 31, 2023. During the last 3 years, it has fallen by -$4.13 million (-62.39%). TBPH annual CAPEX is now -65.64% below its all-time high of $7.24 million, reached on December 31, 2018.TBPH CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH Quarterly CAPEX
$15.00 K
-$21.00 K-58.33%
30 September 2024
Summary:
As of January 23, 2025, TBPH quarterly capital expenditures is $15.00 thousand, with the most recent change of -$21.00 thousand (-58.33%) on September 30, 2024. Over the past year, it has dropped by -$6000.00 (-28.57%). TBPH quarterly CAPEX is now -99.46% below its all-time high of $2.77 million, reached on March 31, 2018.TBPH Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH TTM CAPEX
$819.00 K
-$6000.00-0.73%
30 September 2024
Summary:
As of January 23, 2025, TBPH TTM capital expenditures is $819.00 thousand, with the most recent change of -$6000.00 (-0.73%) on September 30, 2024. Over the past year, it has dropped by -$1.26 million (-60.57%). TBPH TTM CAPEX is now -88.98% below its all-time high of $7.43 million, reached on March 31, 2021.TBPH TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TBPH CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +335.0% | -28.6% | -60.6% |
| 3 y3 years | -62.4% | -98.6% | -80.5% |
| 5 y5 years | -65.6% | -98.8% | -87.6% |
TBPH CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -26.9% | +335.0% | -98.4% | +126.3% | -76.0% | +43.2% |
| 5 y | 5-year | -62.4% | +335.0% | -99.4% | +126.3% | -89.0% | +43.2% |
| alltime | all time | -65.6% | +335.0% | -99.5% | +126.3% | -89.0% | +43.2% |
Theravance Biopharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $15.00 K(-58.3%) | $819.00 K(-0.7%) |
| June 2024 | - | $36.00 K(-60.4%) | $825.00 K(-49.7%) |
| Mar 2024 | - | $91.00 K(-86.6%) | $1.64 M(-34.0%) |
| Dec 2023 | $2.49 M(+335.0%) | $677.00 K(+3123.8%) | $2.49 M(+19.8%) |
| Sept 2023 | - | $21.00 K(-97.5%) | $2.08 M(+3.9%) |
| June 2023 | - | $852.00 K(-9.2%) | $2.00 M(+58.7%) |
| Mar 2023 | - | $938.00 K(+252.6%) | $1.26 M(+120.3%) |
| Dec 2022 | $572.00 K(-83.2%) | $266.00 K(-566.7%) | $572.00 K(-23.7%) |
| Sept 2022 | - | -$57.00 K(-150.4%) | $750.00 K(-59.4%) |
| June 2022 | - | $113.00 K(-54.8%) | $1.85 M(-2.3%) |
| Mar 2022 | - | $250.00 K(-43.7%) | $1.89 M(-44.5%) |
| Dec 2021 | $3.41 M(-48.5%) | $444.00 K(-57.3%) | $3.41 M(-19.0%) |
| Sept 2021 | - | $1.04 M(+566.0%) | $4.21 M(-19.4%) |
| June 2021 | - | $156.00 K(-91.2%) | $5.22 M(-29.8%) |
| Mar 2021 | - | $1.77 M(+42.0%) | $7.43 M(+12.3%) |
| Dec 2020 | $6.62 M(+108.3%) | $1.24 M(-39.3%) | $6.62 M(-0.9%) |
| Sept 2020 | - | $2.05 M(-13.4%) | $6.67 M(+42.0%) |
| June 2020 | - | $2.37 M(+148.2%) | $4.70 M(+61.6%) |
| Mar 2020 | - | $954.00 K(-26.8%) | $2.91 M(-8.4%) |
| Dec 2019 | $3.18 M(-56.1%) | $1.30 M(+1592.2%) | $3.18 M(-5.8%) |
| Sept 2019 | - | $77.00 K(-86.6%) | $3.37 M(-34.8%) |
| June 2019 | - | $576.00 K(-52.8%) | $5.17 M(-9.1%) |
| Mar 2019 | - | $1.22 M(-18.7%) | $5.69 M(-21.4%) |
| Dec 2018 | $7.24 M | $1.50 M(-20.0%) | $7.24 M(+20.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2018 | - | $1.88 M(+71.4%) | $6.00 M(+21.2%) |
| June 2018 | - | $1.09 M(-60.5%) | $4.95 M(+7.8%) |
| Mar 2018 | - | $2.77 M(+986.7%) | $4.59 M(+90.8%) |
| Dec 2017 | $2.41 M(+12.7%) | $255.00 K(-69.1%) | $2.41 M(-5.7%) |
| Sept 2017 | - | $826.00 K(+11.9%) | $2.55 M(+19.3%) |
| June 2017 | - | $738.00 K(+25.7%) | $2.14 M(+4.9%) |
| Mar 2017 | - | $587.00 K(+46.8%) | $2.04 M(-4.5%) |
| Dec 2016 | $2.13 M(-19.3%) | $400.00 K(-3.1%) | $2.13 M(-8.8%) |
| Sept 2016 | - | $413.00 K(-35.3%) | $2.34 M(-10.0%) |
| June 2016 | - | $638.00 K(-6.7%) | $2.60 M(-2.7%) |
| Mar 2016 | - | $684.00 K(+12.9%) | $2.67 M(+1.0%) |
| Dec 2015 | $2.65 M(-14.8%) | $606.00 K(-10.1%) | $2.65 M(-5.7%) |
| Sept 2015 | - | $674.00 K(-5.1%) | $2.81 M(+8.2%) |
| June 2015 | - | $710.00 K(+8.1%) | $2.59 M(+20.9%) |
| Mar 2015 | - | $657.00 K(-14.1%) | $2.14 M(-31.0%) |
| Dec 2014 | $3.11 M(+13.6%) | $765.00 K(+65.9%) | $3.11 M(-8.8%) |
| Sept 2014 | - | $461.00 K(+76.6%) | $3.41 M(+7.0%) |
| June 2014 | - | $261.00 K(-83.9%) | $3.18 M(-11.9%) |
| Mar 2014 | - | $1.62 M(+52.0%) | $3.61 M(+32.2%) |
| Dec 2013 | $2.73 M(+5.6%) | $1.07 M(+349.8%) | $2.73 M(+63.9%) |
| Sept 2013 | - | $237.00 K(-65.7%) | $1.67 M(+16.6%) |
| June 2013 | - | $691.00 K(-6.6%) | $1.43 M(+93.4%) |
| Mar 2013 | - | $740.00 K | $740.00 K |
| Dec 2012 | $2.59 M | - | - |
FAQ
- What is Theravance Biopharma annual capital expenditures?
- What is the all time high annual CAPEX for Theravance Biopharma?
- What is Theravance Biopharma annual CAPEX year-on-year change?
- What is Theravance Biopharma quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Theravance Biopharma?
- What is Theravance Biopharma quarterly CAPEX year-on-year change?
- What is Theravance Biopharma TTM capital expenditures?
- What is the all time high TTM CAPEX for Theravance Biopharma?
- What is Theravance Biopharma TTM CAPEX year-on-year change?
What is Theravance Biopharma annual capital expenditures?
The current annual CAPEX of TBPH is $2.49 M
What is the all time high annual CAPEX for Theravance Biopharma?
Theravance Biopharma all-time high annual capital expenditures is $7.24 M
What is Theravance Biopharma annual CAPEX year-on-year change?
Over the past year, TBPH annual capital expenditures has changed by +$1.92 M (+334.97%)
What is Theravance Biopharma quarterly capital expenditures?
The current quarterly CAPEX of TBPH is $15.00 K
What is the all time high quarterly CAPEX for Theravance Biopharma?
Theravance Biopharma all-time high quarterly capital expenditures is $2.77 M
What is Theravance Biopharma quarterly CAPEX year-on-year change?
Over the past year, TBPH quarterly capital expenditures has changed by -$6000.00 (-28.57%)
What is Theravance Biopharma TTM capital expenditures?
The current TTM CAPEX of TBPH is $819.00 K
What is the all time high TTM CAPEX for Theravance Biopharma?
Theravance Biopharma all-time high TTM capital expenditures is $7.43 M
What is Theravance Biopharma TTM CAPEX year-on-year change?
Over the past year, TBPH TTM capital expenditures has changed by -$1.26 M (-60.57%)